Shinichi Aishima

Shinichi Aishima

Auto-generated profile, based on publicly available information

Shinichi Aishima

Department of Pathology, Hamanomachi Hospital, Fukuoka 810-8539, Japan

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Laboratory Investigation
Verified
Journal Article
Closed access
SAShinichi Aishima
Shinichi Aishima
YNYunosuke Nishihara
Yunosuke Nishihara
TITomohiro Iguchi
Tomohiro Iguchi
KTKenichi Taguchi
Kenichi Taguchi
ATAkinobu Taketomi
Akinobu Taketomi
MTMasazumi Tsuneyoshi
Masazumi Tsuneyoshi

1 July 2003
Verified
Journal Article
Closed access
KSKeishi Sugimachi
Keishi Sugimachi
STShinji Tanaka
Shinji Tanaka
TKToshifumi Kameyama
Toshifumi Kameyama
KTKen-Ichi Taguchi
Ken-Ichi Taguchi
SAShin-Ichi Aishima
Shin-Ichi Aishima
MTMasazumi Tsuneyoshi
Masazumi Tsuneyoshi

1 December 2007 in Human Pathology
Verified
Journal Article
Closed access
PDF file
SAShinichi Aishima
Shinichi Aishima
YKYousuke Kuroda
Yousuke Kuroda
YNYunosuke Nishihara
Yunosuke Nishihara
KTKenichi Taguchi
Kenichi Taguchi
TITomohiro Iguchi
Tomohiro Iguchi
MTMasazumi Tsuneyoshi
Masazumi Tsuneyoshi

1 October 2014
Verified
Journal Article
Closed access
JMJun Muto
Jun Muto
KSKen Shirabe
Ken Shirabe
TYTomoharu Yoshizumi
Tomoharu Yoshizumi
TIToru Ikegami
Toru Ikegami
SAShinichi Aishima
Shinichi Aishima
YMYoshihiko Maehara
Yoshihiko Maehara

1 November 2008 in American Journal of Surgical Pathology
Verified
Journal Article
Closed access
TITomohiro Iguchi
Tomohiro Iguchi
SAShinichi Aishima
Shinichi Aishima
ATAkinobu Taketomi
Akinobu Taketomi
YNYunosuke Nishihara
Yunosuke Nishihara
NFNobuhiro Fujita
Nobuhiro Fujita
MTMasazumi Tsuneyoshi
Masazumi Tsuneyoshi
The fibrous capsule is a unique characteristic of hepatocellular carcinoma (HCC) and acts as a barricade preventing the spread of cancer cells. Infiltration to the capsule (fc-inf) is the invasive feature in HCC; however, there are no reports of a detailed investigation regarding fc-inf. We selected 88 HCCs of ≤5 cm in diameter, when considered together with both the single nodular and the single nodular with extranodular growth types. We classified the infiltrating pattern into 2 types: extracapsular (EC) infiltrating type (n=38), in which cancer cells infiltrated outside the capsule and touched the existing liver parenchyma, and intracapsular (IC) infiltrating type (n=50), in which the infiltrating cancer cells stayed inside the capsule. The distance of infiltration and the capsular thickness were measured and the ratio of capsular infiltration (CI index) was calculated. There were no clinicopathologic differences between the 2 types, but the capsular thickness of IC type was greater than that of EC type (P<0.0001). EC type showed a poorer outcome for the overall survival and the disease-free survival (P=0.0210 and P=0.0115, respectively) and EC type was an independent prognostic factor for a disease-free survival (P=0.0158). However, CI index did not correlate with any clinicopathologic factors or the patient prognosis in IC type. We propose a new definition of fc-inf as a histologic feature of cancer cells penetrating to the liver parenchyma through the fibrous capsule. It may be closely related to the patient prognosis and may therefore, become a new and useful pathologic factor.

1 June 2008 in Human Pathology
Verified
Journal Article
Closed access
SAShinichi Aishima
Shinichi Aishima
YNYunosuke Nishihara
Yunosuke Nishihara
ETEiji Tsujita
Eiji Tsujita
KTKenichi Taguchi
Kenichi Taguchi
YSYuji Soejima
Yuji Soejima
MTMasazumi Tsuneyoshi
Masazumi Tsuneyoshi